| |
| |
|
| Insider
Information: |
Venker Eric |
| Relationship: |
|
| City: |
London |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
484,200 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,510,196 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
484,200 |
|
|
| Total
Value |
$5,510,196 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Roivant Sciences Ltd. |
ROIV |
|
2024-04-20 |
484,200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ROIV |
Roivant Sciences Ltd. |
President & COO |
• • – |
2024-04-20 |
4 |
D |
$10.46 |
$167,381 |
D/D |
(16,002) |
484,200 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
President & COO |
• • – |
2024-03-20 |
4 |
D |
$10.01 |
$160,190 |
D/D |
(16,003) |
500,202 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
President & COO |
• • – |
2024-02-20 |
4 |
D |
$11.54 |
$184,663 |
D/D |
(16,002) |
516,205 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
President & COO |
• • – |
2024-02-09 |
4 |
AS |
$10.92 |
$1,058,694 |
D/D |
(96,950) |
532,207 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
President & COO |
• • – |
2024-02-09 |
4 |
OE |
$3.85 |
$373,258 |
D/D |
96,950 |
629,157 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
President & COO |
• • – |
2024-01-20 |
4 |
D |
$10.35 |
$128,102 |
D/D |
(12,377) |
532,207 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
President & COO |
• • – |
2023-12-20 |
4 |
D |
$9.96 |
$159,390 |
D/D |
(16,003) |
544,584 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
President & COO |
• • – |
2023-11-22 |
4 |
AS |
$8.68 |
$143,645 |
D/D |
(16,549) |
560,587 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
President & COO |
• • – |
2023-10-24 |
4 |
AS |
$8.99 |
$164,166 |
D/D |
(18,261) |
577,136 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
Chief Operating Officer |
• • – |
2023-10-05 |
4 |
AS |
$10.11 |
$1,547,103 |
D/D |
(153,027) |
595,397 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
Chief Operating Officer |
• • – |
2023-10-04 |
4 |
OE |
$3.85 |
$589,154 |
D/D |
153,027 |
748,424 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
Chief Operating Officer |
• • – |
2023-10-03 |
4 |
AS |
$10.25 |
$6,213,765 |
D/D |
(606,221) |
595,397 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
Chief Operating Officer |
• • – |
2023-10-03 |
4 |
OE |
$3.85 |
$2,333,951 |
D/D |
606,221 |
1,201,618 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
Chief Operating Officer |
• • – |
2023-10-02 |
4 |
OE |
$3.85 |
$1,696,895 |
D/D |
440,752 |
1,036,149 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
Chief Operating Officer |
• • – |
2023-10-02 |
4 |
AS |
$10.80 |
$4,760,122 |
D/D |
(440,752) |
595,397 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
President & COO |
• • – |
2023-09-27 |
4 |
AS |
$13.02 |
$6,510,000 |
D/D |
(500,000) |
595,397 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
President & COO |
• • – |
2023-09-27 |
4 |
OE |
$3.85 |
$1,925,000 |
D/D |
500,000 |
1,095,397 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
President & COO |
• • – |
2023-09-22 |
4 |
AS |
$10.19 |
$167,279 |
D/D |
(16,416) |
595,397 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
Chief Operating Officer |
• • – |
2023-09-08 |
4 |
AS |
$12.19 |
$1,297,382 |
D/D |
(106,430) |
611,813 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
Chief Operating Officer |
• • – |
2023-09-08 |
4 |
OE |
$3.85 |
$409,756 |
D/D |
106,430 |
718,243 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
Chief Operating Officer |
• • – |
2023-09-06 |
4 |
AS |
$11.85 |
$70,223 |
D/D |
(5,926) |
611,813 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
Chief Operating Officer |
• • – |
2023-09-06 |
4 |
OE |
$3.85 |
$22,815 |
D/D |
5,926 |
617,739 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
Chief Operating Officer |
• • – |
2023-09-05 |
4 |
AS |
$11.92 |
$873,438 |
D/D |
(73,275) |
611,813 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
Chief Operating Officer |
• • – |
2023-09-05 |
4 |
OE |
$3.85 |
$282,109 |
D/D |
73,275 |
685,088 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
Chief Operating Officer |
• • – |
2023-09-01 |
4 |
AS |
$11.90 |
$175,680 |
D/D |
(14,763) |
611,813 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
